To ask the Scottish Executive what consideration has been given to the risks posed by antipsychotic drugs to dementia patients. As with all medicines, the safety of antipsychotic drugs is continually monitored by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) and the Commission for Human Medicines.